Vnitr Lek 2008, 54(10):945-947
Nukleární kardiologie: postradatelná, či nepostradatelná? - editorial
- Kardiologické oddělení, Kardiovaskulární centrum 1. lékařské fakulty UK a FN Motol, primář prof. MUDr. Josef Veselka, CSc., FESC, FSCAI, FICA
Received: May 28, 2008; Published: October 1, 2008 Show citation
References
- Kamínek M, Hutyra M. Zobrazovací metody v diagnostice viability myokardu. Část 1. Interpretace nálezů při zobrazení viability myokardu pomocí SPECT a PET. Vnitř Lék 2008; 54: 971-978.
Go to PubMed...
- Clark AN, Beller GA. The present role of nuclear cardiology in clinical practice. Q J Nucl Med Imaging 2005; 49: 43-58.
- Meluzín J, Černý J, Groch L et al. Prognostic importance of quantification of myocardial viability in revascularized patients with coronary artery disease and moderate-to-severe left ventricular dysfunction. Int J Cardiol 2003; 90: 23-31.
Go to original source...
Go to PubMed...
- Bateman TM, Prvulovich E. Assessment of prognosis in chronic coronary artery disease. Heart 2004; 90 (Suppl 5): 10-15.
Go to original source...
Go to PubMed...
- Hachamovitch R, Gates S, Friedman J et al. Determinants of risk and its temporal variation in patiens with normal stress myocardial perfusion scans: What is the warranty period of a normal scan? J Am Coll Cardiol 2003; 41: 1329-1340.
Go to original source...
Go to PubMed...
- Pijls NH. Is it time to measure fractional flow reserve in all patients? J Am Coll Cardiol 2003; 41: 1122-1124.
Go to original source...
Go to PubMed...
- Vesely MR, Dilsizian V. Nuclear cardiac stress testing in the era of molecular medicine. J Nucl Med 2008; 49: 399-413.
Go to original source...
Go to PubMed...
- Metelková I, Kamínek J, Budíková M et al. Senzitivita a specificita zátěžového gated SPECT-zobrazení myokardu pro detekci ischemické choroby srdeční: validace nálezů pomocí koronarografie. Cor Vasa 2008; 50: 191-194.
Go to original source...